Biotech News
Ascendis to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
COPENHAGEN, Denmark, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report third quarter 2026 financial results and provide a business update on Thursday, November 12, 2026, before the open of the U.S. financial markets.
